JN: "British Journal of Pharmacology" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Role of T CD4 cells, macrophages, C-low threshold mechanoreceptors and spinal Ca v 3.2 channels in inflammation and related pain-like symptoms in murine inflammatory models.
Autorzy:: Picard E; Inserm, U1107 Neuro-Dol, Pharmacologie Fondamentale et Clinique de la Douleur, Université Clermont Auvergne, Clermont-Ferrand, France.; Faculty of Medicine, ANALGESIA Institute, Clermont-Ferrand, France.; Inserm, U1019, CNRS UMR 9017, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, University of Lille, Lille, France.
Kerckhove N; Inserm, U1107 Neuro-Dol, Pharmacologie Fondamentale et Clinique de la Douleur, Université Clermont Auvergne, Clermont-Ferrand, France.; Faculty of Medicine, ANALGESIA Institute, Clermont-Ferrand, France.; Medical Pharmacology Department, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.
François A; CNRS, INSERM, IGF, Université de Montpellier, Montpellier, France.
Boudieu L; Inserm, U1107 Neuro-Dol, Pharmacologie Fondamentale et Clinique de la Douleur, Université Clermont Auvergne, Clermont-Ferrand, France.; Faculty of Medicine, ANALGESIA Institute, Clermont-Ferrand, France.
Billard E; Inserm U1071, INRA USC2018, M2iSH, Université Clermont Auvergne, Clermont-Ferrand, France.
Carvalho FA; Inserm, U1107 Neuro-Dol, Pharmacologie Fondamentale et Clinique de la Douleur, Université Clermont Auvergne, Clermont-Ferrand, France.; Faculty of Medicine, ANALGESIA Institute, Clermont-Ferrand, France.
Bogard G; Inserm, U1019, CNRS UMR 9017, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, University of Lille, Lille, France.
Gosset P; Inserm, U1019, CNRS UMR 9017, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, University of Lille, Lille, France.
Bourdier J; Inserm, U1107 Neuro-Dol, Pharmacologie Fondamentale et Clinique de la Douleur, Université Clermont Auvergne, Clermont-Ferrand, France.; Faculty of Medicine, ANALGESIA Institute, Clermont-Ferrand, France.
Aissouni Y; Inserm, U1107 Neuro-Dol, Pharmacologie Fondamentale et Clinique de la Douleur, Université Clermont Auvergne, Clermont-Ferrand, France.; Faculty of Medicine, ANALGESIA Institute, Clermont-Ferrand, France.
Bourinet E; CNRS, INSERM, IGF, Université de Montpellier, Montpellier, France.
Eschalier A; Inserm, U1107 Neuro-Dol, Pharmacologie Fondamentale et Clinique de la Douleur, Université Clermont Auvergne, Clermont-Ferrand, France.; Faculty of Medicine, ANALGESIA Institute, Clermont-Ferrand, France.
Daulhac L; Inserm, U1107 Neuro-Dol, Pharmacologie Fondamentale et Clinique de la Douleur, Université Clermont Auvergne, Clermont-Ferrand, France.; Faculty of Medicine, ANALGESIA Institute, Clermont-Ferrand, France.
Mallet C; Inserm, U1107 Neuro-Dol, Pharmacologie Fondamentale et Clinique de la Douleur, Université Clermont Auvergne, Clermont-Ferrand, France.; Faculty of Medicine, ANALGESIA Institute, Clermont-Ferrand, France.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2023 Feb; Vol. 180 (4), pp. 385-400. Date of Electronic Publication: 2022 Nov 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Inflammation*
Chronic Pain*
Mice ; Animals ; Hyperalgesia ; CD4-Positive T-Lymphocytes ; Mechanoreceptors ; Macrophages

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Inflammation, ageing and diseases of the lung: Potential therapeutic strategies from shared biological pathways.
Autorzy:: Faniyi AA; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Hughes MJ; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Scott A; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Belchamber KBR; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Sapey E; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2022 May; Vol. 179 (9), pp. 1790-1807. Date of Electronic Publication: 2022 Jan 21.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Aging*
Inflammation*/drug therapy
Aged ; Humans ; Lung

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Themed issue: Inflammation, repair and ageing.
Autorzy:: Mauro C; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Naylor AJ; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Lord JM; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2022 May; Vol. 179 (9), pp. 1787-1789. Date of Electronic Publication: 2022 Feb 17.
Typ publikacji:: Editorial; Research Support, Non-U.S. Gov't
MeSH Terms:: Aging*
Inflammation*/drug therapy
Humans

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Molecular imaging of cardiovascular inflammation.
Autorzy:: MacRitchie N; Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Noonan J; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Guzik TJ; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Department of Internal Medicine, Jagiellonian University, Collegium Medicum, Kraków, Poland.
Maffia P; Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Department of Pharmacy, University of Naples Federico II, Naples, Italy.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2021 Nov; Vol. 178 (21), pp. 4216-4245. Date of Electronic Publication: 2021 Oct 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Cardiovascular Diseases*/diagnostic imaging
Inflammation*/diagnostic imaging
Humans ; Molecular Imaging

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Protective role of cortistatin in pulmonary inflammation and fibrosis.
Autorzy:: Barriga M; Department of Immunology and Cell Biology, Institute of Parasitology and Biomedicine Lopez-Neyra IPBLN-CSIC, Granada, Spain.
Benitez R; Department of Immunology and Cell Biology, Institute of Parasitology and Biomedicine Lopez-Neyra IPBLN-CSIC, Granada, Spain.
Ferraz-de-Paula V; Department of Immunology and Cell Biology, Institute of Parasitology and Biomedicine Lopez-Neyra IPBLN-CSIC, Granada, Spain.; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Garcia-Frutos M; Department of Immunology and Cell Biology, Institute of Parasitology and Biomedicine Lopez-Neyra IPBLN-CSIC, Granada, Spain.
Caro M; Department of Immunology and Cell Biology, Institute of Parasitology and Biomedicine Lopez-Neyra IPBLN-CSIC, Granada, Spain.
Robledo G; Department of Immunology and Cell Biology, Institute of Parasitology and Biomedicine Lopez-Neyra IPBLN-CSIC, Granada, Spain.
O'Valle F; Pathology Department, School of Medicine, IBIMER, CIBM, University of Granada and Biosanitary Research Institute IBS-Granada, Granada, Spain.
Campos-Salinas J; Department of Immunology and Cell Biology, Institute of Parasitology and Biomedicine Lopez-Neyra IPBLN-CSIC, Granada, Spain.
Delgado M; Department of Immunology and Cell Biology, Institute of Parasitology and Biomedicine Lopez-Neyra IPBLN-CSIC, Granada, Spain.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2021 Nov; Vol. 178 (21), pp. 4368-4388. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Inflammation*/drug therapy
Inflammation*/pathology
Neuropeptides*/pharmacology
Pneumonia*/chemically induced
Pneumonia*/drug therapy
Animals ; Disease Models, Animal ; Fibrosis ; Lipopolysaccharides ; Lung/pathology ; Mice

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Brain control of appetite during sickness.
Autorzy:: Aviello G; Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Cristiano C; Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Luckman SM; Faculty of Biology, Medicine and Health, School of Medical Sciences, University of Manchester, Manchester, UK.
D'Agostino G; Faculty of Biology, Medicine and Health, School of Medical Sciences, University of Manchester, Manchester, UK.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2021 May; Vol. 178 (10), pp. 2096-2110. Date of Electronic Publication: 2020 Aug 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Appetite*
Inflammation*
Brain ; Humans ; Immunity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology.
Autorzy:: Perretti M; The William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, UK.; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, London, UK.
Godson C; Diabetes Complications Research Centre, Conway Institute & School of Medicine, University College Dublin, Dublin, Ireland.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2020 Oct; Vol. 177 (20), pp. 4595-4600. Date of Electronic Publication: 2020 Sep 20.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Inflammation*/drug therapy
Receptors, Formyl Peptide*
Humans ; Receptors, Lipoxin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19?
Autorzy:: Sousa LP; Laboratorio de Imunofamacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.; Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Pinho V; Laboratorio de Imunofamacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.; Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Teixeira MM; Laboratorio de Imunofamacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2020 Sep; Vol. 177 (17), pp. 3898-3904. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: COVID-19 Drug Treatment*
Anti-Inflammatory Agents/*therapeutic use
Inflammation/*drug therapy
Acetates/therapeutic use ; Angiotensin I/therapeutic use ; Animals ; Annexin A1/therapeutic use ; COVID-19/immunology ; Disease Models, Animal ; Docosahexaenoic Acids/therapeutic use ; Humans ; Hydrogen Peroxide/therapeutic use ; Inflammation/immunology ; Inflammation Mediators/immunology ; Mice ; Orthomyxoviridae Infections/drug therapy ; Orthomyxoviridae Infections/immunology ; Oxidants/therapeutic use ; Peptide Fragments/therapeutic use ; Peptides/therapeutic use ; Phosphodiesterase 4 Inhibitors/therapeutic use ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/immunology ; Rolipram/therapeutic use ; Vasodilator Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection.
Autorzy:: Rosli S; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia.
Kirby FJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia.
Lawlor KE; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia.
Rainczuk K; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia.
Drummond GR; Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, Victoria, Australia.
Mansell A; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia.
Tate MD; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Oct; Vol. 176 (19), pp. 3834-3844. Date of Electronic Publication: 2019 Aug 19.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Inflammation/*drug therapy
NLR Family, Pyrin Domain-Containing 3 Protein/*antagonists & inhibitors
Orthomyxoviridae Infections/*drug therapy
Probenecid/*pharmacology
Receptors, Purinergic P2X7/*metabolism
Thiazoles/*pharmacology
Animals ; Cells, Cultured ; Drug Repositioning ; Female ; Inflammasomes/drug effects ; Inflammasomes/metabolism ; Inflammation/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Orthomyxoviridae Infections/metabolism ; Probenecid/administration & dosage ; Thiazoles/administration & dosage

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Sigma-1 receptor modulates neuroinflammation associated with mechanical hypersensitivity and opioid tolerance in a mouse model of osteoarthritis pain.
Autorzy:: Carcolé M; Neuropharmacology Lab, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.
Kummer S; Neuropharmacology Lab, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.
Gonçalves L; Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.
Zamanillo D; Drug Discovery and Preclinical Development, Laboratories Esteve, Barcelona Science Park, Barcelona, Spain.
Merlos M; Drug Discovery and Preclinical Development, Laboratories Esteve, Barcelona Science Park, Barcelona, Spain.
Dickenson AH; Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.
Fernández-Pastor B; Drug Discovery and Preclinical Development, Laboratories Esteve, Barcelona Science Park, Barcelona, Spain.
Cabañero D; Neuropharmacology Lab, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.
Maldonado R; Neuropharmacology Lab, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Oct; Vol. 176 (20), pp. 3939-3955. Date of Electronic Publication: 2019 Sep 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Disease Models, Animal*
Hyperalgesia/*metabolism
Inflammation/*metabolism
Osteoarthritis/*metabolism
Pain/*metabolism
Receptors, sigma/*metabolism
Analgesics, Opioid/pharmacology ; Animals ; Dose-Response Relationship, Drug ; Drug Tolerance ; Hyperalgesia/drug therapy ; Inflammation/drug therapy ; Injections, Intra-Articular ; Iodoacetic Acid/administration & dosage ; Male ; Mice ; Morphine/pharmacology ; Morpholines/pharmacology ; Osteoarthritis/chemically induced ; Osteoarthritis/drug therapy ; Pain/chemically induced ; Pain/drug therapy ; Pyrazoles/pharmacology ; Receptors, sigma/antagonists & inhibitors ; Sigma-1 Receptor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Salt, inflammation, IL-17 and hypertension.
Autorzy:: Wenzel UO; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bode M; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kurts C; Institute of Molecular Medicine and Experimental Immunology, Rheinische Friedrich-Wilhelms University, Bonn, Germany.
Ehmke H; Department of Cellular and Integrative Physiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Jun; Vol. 176 (12), pp. 1853-1863. Date of Electronic Publication: 2018 Jun 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Hypertension/*immunology
Inflammation/*immunology
Interleukin-17/*immunology
Animals ; Blood Pressure/drug effects ; Blood Pressure/immunology ; Humans ; Hypertension/chemically induced ; Inflammation/chemically induced ; Interleukin-17/antagonists & inhibitors ; Sodium Chloride, Dietary/administration & dosage ; Sodium Chloride, Dietary/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: 1,2,3,4,6-Penta-O-galloyl-β-d-glucose modulates perivascular inflammation and prevents vascular dysfunction in angiotensin II-induced hypertension.
Autorzy:: Mikolajczyk TP; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.; Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, Krakow, Poland.
Nosalski R; Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, Krakow, Poland.; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Skiba DS; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Koziol J; Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, Krakow, Poland.
Mazur M; Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, Krakow, Poland.
Justo-Junior AS; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Kowalczyk P; Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, Warsaw, Poland.
Kusmierczyk Z; Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, Warsaw, Poland.
Schramm-Luc A; Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, Krakow, Poland.
Luc K; Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, Krakow, Poland.
Maffia P; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.; Department of Pharmacy, University of Naples Federico II, Naples, Italy.
Graham D; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Kiss AK; Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, Warsaw, Poland.
Naruszewicz M; Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, Warsaw, Poland.
Guzik TJ; Department of Internal and Agricultural Medicine, Jagiellonian University Medical College, Krakow, Poland.; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Jun; Vol. 176 (12), pp. 1951-1965. Date of Electronic Publication: 2019 Mar 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hydrolyzable Tannins/*pharmacology
Hypertension/*drug therapy
Inflammation/*drug therapy
Ventricular Dysfunction/*drug therapy
Angiotensin II/administration & dosage ; Animals ; Humans ; Hydrolyzable Tannins/chemistry ; Hydrolyzable Tannins/isolation & purification ; Hypertension/chemically induced ; Inflammation/metabolism ; Injections, Subcutaneous ; Male ; Mice ; Mice, Inbred C57BL ; Oenothera/chemistry ; Tumor Cells, Cultured ; Ventricular Dysfunction/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension.
Autorzy:: Carnagarin R; Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, The University of Western Australia, Perth, WA, Australia.
Matthews V; Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, The University of Western Australia, Perth, WA, Australia.
Zaldivia MTK; Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Vic, Australia.; Department of Medicine, Monash University, Royal Perth Hospital, Perth, WA, Australia.
Peter K; Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Vic, Australia.; Department of Medicine, Monash University, Royal Perth Hospital, Perth, WA, Australia.
Schlaich MP; Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, The University of Western Australia, Perth, WA, Australia.; Department of Cardiology, Royal Perth Hospital, Perth, WA, Australia.; Department of Nephrology, Royal Perth Hospital, Perth, WA, Australia.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Jun; Vol. 176 (12), pp. 1839-1852. Date of Electronic Publication: 2018 Sep 25.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Hypertension/*immunology
Immune System Diseases/*immunology
Inflammation/*immunology
Sympathetic Nervous System/*immunology
Animals ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Semaphorin-3E attenuates intestinal inflammation through the regulation of the communication between splenic CD11C T-cells.
Autorzy:: Kermarrec L; Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
Eissa N; Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.; Children Research Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.; Department of Internal Medicine Section of Gastroenterology, IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
Wang H; Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
Kapoor K; Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
Diarra A; Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
Gounni AS; Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
Bernstein CN; Department of Internal Medicine Section of Gastroenterology, IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
Ghia JE; Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.; Children Research Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.; Department of Internal Medicine Section of Gastroenterology, IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 May; Vol. 176 (9), pp. 1235-1250. Date of Electronic Publication: 2019 Apr 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: CD11c Antigen/*metabolism
CD4-Positive T-Lymphocytes/*metabolism
Colitis, Ulcerative/*drug therapy
Inflammation/*metabolism
Intestinal Mucosa/*metabolism
Semaphorins/*metabolism
Animals ; CD4-Positive T-Lymphocytes/cytology ; Colitis, Ulcerative/chemically induced ; Colitis, Ulcerative/metabolism ; Dextran Sulfate ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Spleen/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Inhibition of Ca v 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation.
Autorzy:: Picard E; Université Clermont Auvergne, INSERM, CHU, NEURO-DOL Basics & Clinical Pharmacology of Pain, F-63000 Clermont-Ferrand, France.; ANALGESIA Institute, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Carvalho FA; Université Clermont Auvergne, INSERM, CHU, NEURO-DOL Basics & Clinical Pharmacology of Pain, F-63000 Clermont-Ferrand, France.; ANALGESIA Institute, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Agosti F; CNRS, INSERM, LABEX ICST, IGF, Université Montpellier, Montpellier, France.
Bourinet E; CNRS, INSERM, LABEX ICST, IGF, Université Montpellier, Montpellier, France.
Ardid D; Université Clermont Auvergne, INSERM, CHU, NEURO-DOL Basics & Clinical Pharmacology of Pain, F-63000 Clermont-Ferrand, France.; ANALGESIA Institute, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Eschalier A; Université Clermont Auvergne, INSERM, CHU, NEURO-DOL Basics & Clinical Pharmacology of Pain, F-63000 Clermont-Ferrand, France.; ANALGESIA Institute, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Daulhac L; Université Clermont Auvergne, INSERM, CHU, NEURO-DOL Basics & Clinical Pharmacology of Pain, F-63000 Clermont-Ferrand, France.; ANALGESIA Institute, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Mallet C; Université Clermont Auvergne, INSERM, CHU, NEURO-DOL Basics & Clinical Pharmacology of Pain, F-63000 Clermont-Ferrand, France.; ANALGESIA Institute, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Apr; Vol. 176 (7), pp. 950-963. Date of Electronic Publication: 2019 Mar 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Calcium Channels, T-Type/*physiology
Colon/*physiopathology
Inflammation/*physiopathology
Animals ; Benzeneacetamides/pharmacology ; Calcium Channel Blockers/pharmacology ; Calcium Channels, T-Type/genetics ; Colon/drug effects ; Colon/immunology ; Dextran Sulfate ; Disease Models, Animal ; Ethosuximide/pharmacology ; Ganglia, Spinal/drug effects ; Ganglia, Spinal/physiology ; Heterocyclic Compounds, 2-Ring/pharmacology ; Inflammation/chemically induced ; Inflammation/immunology ; Inflammatory Bowel Diseases/physiopathology ; Interleukin-6/immunology ; Irritable Bowel Syndrome/physiopathology ; Male ; Mice, Inbred C57BL ; Mice, Knockout ; Nociceptors/drug effects ; Nociceptors/physiology ; Pyridines/pharmacology ; Sulfonamides/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Modulation of α-adrenoceptor signalling protects photoreceptors after retinal detachment by inhibiting oxidative stress and inflammation.
Autorzy:: Li T; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yang S; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.
She X; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yan Q; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang P; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhu H; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China.
Wang F; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China.
Luo X; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Key Laboratory of Fundus Diseases, Shanghai, China.
Sun X; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Key Laboratory of Fundus Diseases, Shanghai, China.; Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Mar; Vol. 176 (6), pp. 801-813. Date of Electronic Publication: 2019 Jan 30.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Adrenergic alpha-1 Receptor Antagonists/*pharmacology
Adrenergic beta-2 Receptor Agonists/*pharmacology
Inflammation/*prevention & control
Oxidative Stress/*drug effects
Photoreceptor Cells/*drug effects
Protective Agents/*pharmacology
Receptors, Adrenergic, alpha-1/*metabolism
Signal Transduction/*drug effects
Adrenergic alpha-1 Receptor Antagonists/administration & dosage ; Adrenergic beta-2 Receptor Agonists/administration & dosage ; Animals ; Apoptosis/drug effects ; Disease Models, Animal ; Doxazosin/administration & dosage ; Doxazosin/pharmacology ; Guanabenz/administration & dosage ; Guanabenz/pharmacology ; Hyaluronic Acid/administration & dosage ; Inflammation/chemically induced ; Inflammation/pathology ; Injections, Intraperitoneal ; Male ; Protective Agents/administration & dosage ; Rats ; Rats, Inbred BN

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: A novel nitroalkene-α-tocopherol analogue inhibits inflammation and ameliorates atherosclerosis in Apo E knockout mice.
Autorzy:: Rodriguez-Duarte J; Laboratory of Vascular Biology and Drug Development, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay.; Departmento de Química Orgánica, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
Galliussi G; Laboratory of Vascular Biology and Drug Development, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Dapueto R; Laboratory of Vascular Biology and Drug Development, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay.; Departmento de Química Orgánica, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
Rossello J; Analytical Biochemistry and Proteomics Unit, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Malacrida L; Analytical Biochemistry and Proteomics Unit, Institut Pasteur de Montevideo, Montevideo, Uruguay.; Pathophysiology Department, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Kamaid A; Analytical Biochemistry and Proteomics Unit, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Schopfer FJ; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.
Escande C; Laboratory of Metabolic Diseases and Aging, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay.
López GV; Laboratory of Vascular Biology and Drug Development, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay.; Departmento de Química Orgánica, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
Batthyány C; Laboratory of Vascular Biology and Drug Development, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay.; Analytical Biochemistry and Proteomics Unit, Institut Pasteur de Montevideo, Montevideo, Uruguay.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Mar; Vol. 176 (6), pp. 757-772. Date of Electronic Publication: 2019 Feb 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anti-Inflammatory Agents/*pharmacology
Antioxidants/*pharmacology
Atherosclerosis/*drug therapy
Cyclopentanes/*pharmacology
Inflammation/*drug therapy
Nitro Compounds/*pharmacology
alpha-Tocopherol/*analogs & derivatives
alpha-Tocopherol/*pharmacology
Animals ; Anti-Inflammatory Agents/chemical synthesis ; Anti-Inflammatory Agents/chemistry ; Antioxidants/chemical synthesis ; Antioxidants/chemistry ; Atherosclerosis/metabolism ; Cytokines/antagonists & inhibitors ; Cytokines/metabolism ; Female ; Inflammation/metabolism ; Macrophages/drug effects ; Mice ; Mice, Inbred C57BL ; Mice, Knockout, ApoE ; Molecular Structure ; RAW 264.7 Cells

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Prostaglandin-cytokine crosstalk in chronic inflammation.
Autorzy:: Yao C; Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.
Narumiya S; Alliance Laboratory for Advanced Medical Research and Department of Drug Discovery Medicine, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Feb; Vol. 176 (3), pp. 337-354. Date of Electronic Publication: 2018 Dec 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Cytokines/*metabolism
Inflammation/*metabolism
Inflammation Mediators/*metabolism
Prostaglandins/*metabolism
Animals ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Seselin ameliorates inflammation via targeting Jak2 to suppress the proinflammatory phenotype of macrophages.
Autorzy:: Feng L; State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China.
Sun Y; State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China.
Song P; Jiangsu Centre for Research and Development of Medicinal Plants, Institute of Botany Jiangsu Province, Chinese Academy of Sciences, Nanjing, China.
Xu L; State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China.
Wu X; State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China.
Wu X; State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China.
Shen Y; State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China.
Sun Y; State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China.
Kong L; State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China.
Wu X; State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China.
Xu Q; State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Jan; Vol. 176 (2), pp. 317-333. Date of Electronic Publication: 2018 Dec 04.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anti-Inflammatory Agents, Non-Steroidal/*pharmacology
Coumarins/*pharmacology
Inflammation/*drug therapy
Janus Kinase 2/*antagonists & inhibitors
Macrophages/*drug effects
Sepsis/*drug therapy
Animals ; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage ; Coumarins/administration & dosage ; Disease Models, Animal ; Female ; Inflammation/metabolism ; Janus Kinase 2/metabolism ; Macrophages/metabolism ; Mice ; Mice, Inbred C57BL ; Molecular Docking Simulation ; Phenotype ; Receptors, Interferon/antagonists & inhibitors ; Receptors, Interferon/metabolism ; STAT1 Transcription Factor/antagonists & inhibitors ; STAT1 Transcription Factor/metabolism ; Sepsis/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Immunomodulatory tetracyclines shape the intestinal inflammatory response inducing mucosal healing and resolution.
Autorzy:: Garrido-Mesa J; CIBER-EHD, Department of Pharmacology, ibs. GRANADA, Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.
Rodríguez-Nogales A; CIBER-EHD, Department of Pharmacology, ibs. GRANADA, Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.
Algieri F; CIBER-EHD, Department of Pharmacology, ibs. GRANADA, Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.
Vezza T; CIBER-EHD, Department of Pharmacology, ibs. GRANADA, Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.
Hidalgo-Garcia L; CIBER-EHD, Department of Pharmacology, ibs. GRANADA, Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.
Garrido-Barros M; CIBER-EHD, Department of Pharmacology, ibs. GRANADA, Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.
Utrilla MP; CIBER-EHD, Department of Pharmacology, ibs. GRANADA, Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.
Garcia F; Clinical Microbiology Service, Hospital Universitario San Cecilio, ibs. GRANADA, Red de, Investigación en SIDA, Granada, Spain.
Chueca N; Clinical Microbiology Service, Hospital Universitario San Cecilio, ibs. GRANADA, Red de, Investigación en SIDA, Granada, Spain.
Rodriguez-Cabezas ME; CIBER-EHD, Department of Pharmacology, ibs. GRANADA, Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.
Garrido-Mesa N; School of Health, Sport and Bioscience, University of East London, London, UK.
Gálvez J; CIBER-EHD, Department of Pharmacology, ibs. GRANADA, Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2018 Dec; Vol. 175 (23), pp. 4353-4370. Date of Electronic Publication: 2018 Oct 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anti-Inflammatory Agents, Non-Steroidal/*pharmacology
Immunologic Factors/*pharmacology
Inflammation/*drug therapy
Intestines/*drug effects
Intestines/*pathology
Mucous Membrane/*drug effects
Tetracyclines/*pharmacology
Animals ; Colitis/chemically induced ; Colitis/drug therapy ; Colitis/immunology ; Dextran Sulfate ; Inflammation/immunology ; Inflammation/pathology ; Mice ; Mucous Membrane/immunology ; Mucous Membrane/pathology ; RAW 264.7 Cells

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""British Journal of Pharmacology"" wg kryterium: JN

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Język

Rok publikacji